Showing results (321-330 of 563) with videos related to
Sort By:
Pageof 57
British Medical Journal (Clinical Research Ed.)|February 13, 1982
Psychological and social evaluation in cases of deliberate self-poisoning seen in an accident departmentR Gardner, R Hanka, S J Roberts, et al.The Pediatric Infectious Disease Journal|December 16, 2016
Recurrent Clostridium difficile Infection in Children: Patient Risk Factors and Markers of Intestinal InflammationMaribeth R Nicholson, Jonathan D Crews, Jeffrey R Starke, et al.The British Journal of Psychiatry : the Journal of Mental Science|June 2, 2010
What's so special about conversion disorder? A problem and a proposal for diagnostic classificationRichard A Kanaan, Alan Carson, Simon C Wessely, et al.Journal of Dual Diagnosis|January 10, 2022
Catatonic Episodes Related to Substance Use: A Cross-Sectional Study Using Electronic Healthcare RecordsSu Ying Yeoh, Emmert Roberts, Fraser Scott, et al.Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|June 11, 2019
J-2156, a somatostatin receptor type 4 agonist, alleviates mechanical hyperalgesia in a rat model of chronic low back painThomas S W Park, Nemat Khan, Andy Kuo, et al.Australasian Psychiatry : Bulletin of Royal Australian and New Zealand College of Psychiatrists|June 19, 2026
Vascular risk factors in maintenance versus acute electroconvulsive therapy: A retrospective case-control study from a regional Australian serviceFesochi Atulayo, Matthew Jy Kang, Kim S Carey, et al.Journal of Medicinal Chemistry|October 1, 1983
Substituted (2-phenoxyphenyl)acetic acids with antiinflammatory activity. 2D C Atkinson, K E Godfrey, P L Myers, et al.Scientific Reports|July 6, 2021
Characterizing the differences between multisystem inflammatory syndrome in children and Kawasaki diseaseMaskit Bar-Meir, Alex Guri, Max E Godfrey, et al.Psychological Medicine|May 2, 2008
The neural correlates of fatigue: an exploratory imaginal fatigue provocation study in chronic fatigue syndromeX Caseras, D Mataix-Cols, K A Rimes, et al.Patient Preference and Adherence|July 28, 2018
Treatment satisfaction significantly improves in patients with multiple sclerosis switching from interferon beta therapy to peginterferon beta-1a every 2 weeksBarry Hendin, Robert T Naismith, Sibyl E Wray, et al.Pageof 57